Competitive Price API CAS 159351-69-6 Everolimus Powder

CAS No.: 159351-69-6
Formula: C53h83no14
EINECS: 621-003-9
Environmental Protection: Yes
Certification: ISO, SGS
Color: White
Customization:
Manufacturer/Factory, Trading Company
Gold Member Since 2018

Suppliers with verified business licenses

Shaanxi, China
to see all verified strength labels (9)

Basic Info.

Classification
Intermediates & Fine Chemicals
Function
Immunosuppressant
Appearance
Powder
Price
Competitive
Delivery
Fast
Storage
Cool Dried Storage
Shelf Life
2 Years
Transport Package
Foil Bag/Drum/as Per Your Request
Specification
content ≧ 99%
Trademark
IKNOW
Origin
China

Product Description

Competitive Price API CAS 159351-69-6 Everolimus Powder

Introduction
 
Product Name: Everolimus
Synonyms: Everolimus powder;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine, rapamycin deriv;Everolimus solution ;Everolimus, >=98%;42-O-(2-Hydroxyethyl)-rapamycin;Certica;Everolimus(mixture of isomers);Rapamycin, 42-O-(2-hydroxyethyl)-
CAS: 159351-69-6
MF: C53H83NO14
MW: 958.232
EINECS: 621-003-9
Product Categories: Akt;mTOR;All Inhibitors;Inhibitors;PI3K;Intermediates & Fine Chemicals;Pharmaceuticals;Inhibitor;Antineoplastic protein kinase inhibitors;mTOR inhibitor;Certican, Zortress, Afinitor;Anti-cancer&immunity;PI3K/Akt/mTOR;Everolimus
Molecular Structure:                            Competitive Price API CAS 159351-69-6 Everolimus Powder

Everolimus is a derivative of Rapamycin (sirolimus), and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor. It is currently used as an immunosuppressant to prevent rejection of organ transplants. In a similar fashion to other mTOR inhibitors Everolimus' effect is solely on the mTORC1 protein and not on the mTORC2 protein.


Everolimus is indicated for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer (advanced HR+ BC) in combination with exemestane, after failure of treatment with letrozole or anastrozole. Indicated for the treatment of adult patients with progressive neuroendocrine tumors of pancreatic origin (PNET) with unresectable, locally advanced or metastatic disease. Indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib. Indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. Indicated in pediatric and adult patients with tuberous sclerosis complex (TSC) for the treatment of subependymal giant cell astrocytoma (SEGA) that requires therapeutic intervention but cannot be curatively resected.

Function
 
Everolimus may have a role in heart transplantation, as it has been shown to reduce chronic allograft vasculopathy in such transplants. It also may have a similar role to sirolimus in kidney and other transplants.
 
Although, sirolimus had generated fears over use of m-TOR inhibitors in liver transplantation recipients, due to possible early hepatic artery thrombosis and graft loss, use of everolimus in the setting of liver transplantation is promising. Jeng et al., in their study of 43 patients, concluded the safety of everolimus in the early phase after living donor liver transplantation. In their study, no hepatic artery thrombosis or wound infection was noted. Also, a possible role of everolimus in reducing the recurrence of hepatocellular carcinoma after liver transplantation was correlated. A target trough level of 3 ng/mL at 3 months was shown to be beneficial in recipients with pre-transplant renal dysfunction. In their study, 6 of 9 renal failure patients showed significant recovery of renal function, whereas 3 showed further deterioration, one of whom required hemodialysis.

Packing & Shipment
 
Competitive Price API CAS 159351-69-6 Everolimus Powder


Competitive Price API CAS 159351-69-6 Everolimus PowderCompetitive Price API CAS 159351-69-6 Everolimus Powder

Quality Control of Health Sources

1) A system in accordance with GMP standard, supervision on whole production process.
2) Health Sources is equipped with advanced detecting device, such as AFS, GC, HPLC, UV etc, supply the
Detailed Certificate of Analysis.

3) Procurement-Strictly on selecting raw materials.
4) Production-Strictly according to the standard specifications, conform to USP, EP, BP, CP, AJI, FCC etc
Pharmaceutical and/or food standards.

5) Warehousing and storage:Clear and dry condition with suitable temperature.
6) Transportation - Audit and supervise the logistics environment to ensure storage safety.
7) Keep samples for all batches goods to be traceable in case of quality discrepance.


Competitive Price API CAS 159351-69-6 Everolimus Powder


Certification

Competitive Price API CAS 159351-69-6 Everolimus Powder


Competitive Price API CAS 159351-69-6 Everolimus Powder

Competitive Price API CAS 159351-69-6 Everolimus Powder
 
Q1:Which kind of payment terms do you accept?
For small order,you can pay by T/T or Western Union ,nomal order by T/T to our company account.

Q2:Can you give me a discount price?
Surely,It depend on your quantity.

Q3:How can I get a sample?
Free samples is available,but freight charges will be at your account and the charges will be return to you or deduct from your order in the future.

Q4:How to confirm the Product Quality before placing orders?
You can get free samples for some products,you only need to pay the shipping cost or arrange a courier to us and take the samples.You can send us your product specifications and requests,we will manufacture the products according to your requests.

Q5:How do you treat quality complaint?
First of all, our quality control will reduce the quality problem to near zero.If there is a real quality problem caused by us, we will send you free goods for replacement or refund yo
u

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2018

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company
Registered Capital
3000000 RMB
Plant Area
501~1000 square meters